sv se
  • New mechanism of action
  • Fungal infection
  • Bacterial vaginosis
  • Non antibiotic
Bacterial vaginosis is very common, especially in women of childbearing age. Within the EU, between 15 and 45 million women are affected by bacterial vaginosis every year. The symptoms of bacterial vaginosis can be painful; it hurts, burns and can also smell bad. The infection is caused by an imbalance of the vaginal and is treated with antibiotics. pHyph is the first antibiotic-free treatment expected to cure bacterial vaginosis and prevent the infection from recurring.
CLINICAL TRIALS ONGOING
The first two clinical studies on pHyph treatment are ongoing. The clinical trials are performed in cooperation with gynaecologists in southern Sweden. The expected outome of these studies is that pHyph will prove to have an effect onbacterial vaginosis. Read more >>
kartaGedea Biotech AB
Medicon Village
Scheelevägen 2
223 81 Lund
Sweden
Annette Säfholm, CEO
annette.safholm@gedeabiotech.com
+46 (0) 708 - 91 86 81
nyhetsbrev
Eit